Wednesday 18 October 2017
Contact US    |    Archive
PR
28 days ago

Sanofi and NIH researchers develop three-in-one antibodies as a potential breakthrough intervention for HIV/AIDS

CAMBRIDGE, Mass., Sept. 20, 2017 /PRNewswire/ -- In a landmark study published in the journal Scienc

Read on the original site


Hashtags:   

Sanofi

 | 

and

 | 

NIH

 | 

researchers

 | 

develop

 | 

three

 | 

one

 | 

antibodies

 | 

potential

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries